GLENMEDE TRUST CO NA - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$9,000
-18.2%
2000.0%0.00%
Q2 2020$11,000
-71.1%
200
-69.0%
0.00%
Q1 2020$38,0000.0%6460.0%0.00%
Q4 2019$38,000
+245.5%
646
+213.6%
0.00%
Q3 2019$11,000
-8.3%
2060.0%0.00%
Q2 2019$12,000
-25.0%
2060.0%0.00%
Q1 2019$16,000
+45.5%
206
-6.8%
0.00%
Q4 2018$11,000
+10.0%
221
+10.5%
0.00%
Q3 2018$10,0000.0%2000.0%0.00%
Q1 2018$10,0000.0%2000.0%0.00%
Q4 2017$10,0000.0%2000.0%0.00%
Q3 2017$10,000
-65.5%
200
-72.4%
0.00%
Q2 2017$29,0000.0%7240.0%0.00%
Q1 2017$29,000
-12.1%
724
+2.0%
0.00%
Q4 2016$33,000
+32.0%
7100.0%0.00%
Q3 2016$25,000
-34.2%
710
-58.5%
0.00%
Q2 2016$38,000
+850.0%
1,710
+1454.5%
0.00%
Q1 2016$4,000
-33.3%
1100.0%0.00%
Q4 2015$6,0001100.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders